Special Offers for COVID-19 Researchers
DISCOUNTS & FAST-TRACKING PROMOTIONS
|AbBioSci||15%-20% off. COVID19 related products and services|
|ACGT, Inc. (CLIA Compliant)||10% for any non-regulatory (i.e. GLP or GMP) Next Generation Sequencing service plus prioritization in our project queue.|
|Advaita Bioinformatics||We at Advaita Bioinformatics are organizing and coordinating a network of experts with resources (samples, data, equipment, reagents) and expertise to collaborate, share knowledge, and expedite discoveries about SARS-CoV-2 and the human host response to COVID-19. As our own contribution, we will be happy to analyze COVID-19 data shared with us, as well as contribute our expertise, at NO COST.|
|Affina Biotechnologies, Inc.||We offer binding and protein characterization services for Covid-19 at a 20% discount to our usual prices.|
|Amaryllis Nucleics||We have a special offer on our 4hr, easy-to-use, strand-specific RNA-seq kit. We would like to offer a 50% discount for COVID-19 researchers that need to do RNA sequencing to help solve this crisis. That would bring the price per sample for COVID-19 researchers down to $10/reaction for single indexing ($10.50 for dual and $12.50 for unique dual indexing).|
|Applied Pathology Systems||~20% discount for projects in COVID-19 researches.|
|Araneae Biotech Consulting LLC||50% off hourly rate on clinical, medical, and regulatory affairs work for any written product (submission, protocol, study synopsis, etc)|
|BioAssay Systems||15% discount for any researchers focusing on COVID-19 through the month of May 2020. When requesting a quote for our services, simply mention this promotion with an explanation of how your research is addressing COVID-19.
We will also be offering a 15% discount on all our assay kits when purchased from our website (www.bioassaysys.com) using the code COVID19 at checkout. This discount will be available through the end of May 2020 as well.
|Blue Heron Biotech, LLC.||20% off all Covid-19 de novo gene synthesis projects.$180 Covid-19(SARS-CoV-2) full nucleocapsid phosphoprotein (N) gene in puc vector . Gene Size 1260 bp. Sequences obtained from GenBank: MN908947.3. and deliverable is 5ug of plasmid DNA. $150 Covid-19(SARS-CoV-2) full ORF3A gene in puc vector. Gene Size 828 bp GenBank. Sequences obtained from GenBank: MN908947.3. and deliverable is 5ug of plasmid DNA
|Charles River||Prioritizing COVID-19 related research projects|
|Cyclolab||Free feasibilty study for formulation development mainly based on cyclodextrins (remdesivir is also cyclodextrin-enabled). Cyclolab is ready to evaluate any antiviral small molecule candidate with limited water solubility to understand if cyclodextrins are a viable solution to reach the target concentration.|
|Dalton Bioanalytics||Multi-omic research services for COVID-19 patient plasma samples free of charge (given they meet criteria for minimum sample size, proper study design, etc.).|
|Dante Labs||Whole genome sequencing services of individuals with COVID-19 to researchers, at special prices, and also 200 free Whole Genome Sequencing for research projects on COVID-19.|
|DHMRI Services, Inc.||We are providing our services at cost (no profit mark-up at all) with expedited timelines.|
|e-Zyvec||Priority and fast-track for all projects, with free project management, until april 30 2020|
|First Choice Bio LLC||10% off of all our primary cell products for COVID-19 researchers.|
|FlowKnowHow LLC||Flexible rates, deferred payment, as well as working on a collaboration-basis (i.e. with or without payment) on any SARS-CoV-2 / Covid-19 related projects.|
|G&L Scientific||15% discount for COVID-19 researcher companies who need Regulatory or Quality assistance.|
|GnomeDX||15% discount on any contract assay services for COVID-19 (standard testing or custom probes).|
|Helix BioStructures LLC||Helix will provide "at cost" structural biology services for projects specifically related to COVID-19 research.|
|Hybrigenics Services SAS||We are offering 20% discounts on all of our Y2H screening services as well as synthetic nanobody services.|
|IDEXX BioAnalytics||10% for all COVID-19 related research or your institution’s contract discount, whichever is greater.|
|Innovative Informatica Technologies||Up to 50% discount for any of our computational discovery (In-silico tools such as virtual screening, docking, MD simulations) services for COVID-19|
|InSphero, Brunswick Maine||Free safety testing for exploratory COVID-19 medications and coronavirus (SARS-COV-2) vaccine formulations. These COVID-19 tests will be based on InSphero‘s 3D InSight™ Human Liver models and available to any organization (academic, governmental or industrial) that wants to test their treatments in development.|
|Kinomica Ltd||10% discount for any new contract/ business associated with COVID drug trials.|
|Labii Inc.||Free ELN & LIMS for COVID-19 related research.|
|Lipotype GmbH||Priority to confirmed COVID-19 patient samples for lipid analysis based on Lipotype Shotgun Lipidomics Technology.|
|Loop Genomics||20% discount on this service: Small Genome Assembly (up to 4MB). LoopSeq Genome Sequencing to include: library preparation & single molecule counting long-read sequencing with 1/25k error rate. --for all COVID-19 research project|
|Macromoltek, Inc||Discounted access to our antibody designs.|
|McGill University and Genome Quebec Innovation Centre||Grant awarded to COVID-19 researchers. The funded projects would have access to our Core platform genomics services.|
|Med Chem 101, LLC||Discounts on COVID-19 candidate inhibitors: N4-Hydroxycytidine; Camostat mesilate; Hydroxychloroquine; Chloroquine; And others|
|MiTeGen||Priority X-Ray Crystallography and Cryo-EM services for any COVID-19 research projects|
|Nanome, Inc||1. Free IT consultation to increase your remote collaboration efforts with Nanome (submit quote request for info)
2. Free or significantly reduced pricing for additional licenses based on the ability to pay.
|NBS Biologicals, Huntingdon Cambridgeshire||Rush service free of charge|
|NorthEast BioLab||50% Discount to Biotech on COVID-19 related Ligand Binding Assay (LBA) Development and Multiplex testing|
|Novabiosis||30% discount on all our product and 40% off our lung cell product until June|
|Novogene Corporation||Lab Assistance Program (for COVID-19 research orgs in need only) Novogene is offering free shipping, free sample storage, discounted extraction services, as well as a $50 sequencing credit to support researchers|
|Nucleo Life Sciences||Priority services to companies developing small molecule therapeutics for COVID-19|
|OZ Biosciences USA, INC.||20% discount on our viral applications products including kits for capturing, concentrating and storing viruses.|
|PAASP GmbH||10-30% discount on our services. This applies especially for our remote data analysis and evaluation protocols.|
|Paragon Language Services Inc.||15% discount on translations related to COVID-19 research. Research papers, protocols, clinical trial recruiting, reports, etc.|
|Perfectus Biomed||Fast track testing service for products designed to kill coronavirus|
|Pharmidex Pharmaceutical Services||PK and Toxicology services with Bioanalysis with high priority and fast tracking of samples given to COVID-19 researches.|
|PhenoSwitch Bioscience - Expert services in mass spectrometry||1st project at same price they normally have for the same service level. We can put our expertise at use and make data analysis support, consulting and project management at low cost or provide a package of free of charge hours.|
|Precision for Medicine||24hr shipping for biospecimens|
|PreScouter, Inc.||PreScouter is offering a discount ranging from 5%-15%, depending on the size and complexity of your project, on any Covid-19 focused projects.|
|Quick Biology Inc.||5-30% discounts on different NGS projects ranging from WGS, RNA-seq and amplicon seq related to COVID-19.|
|Redbud Labs, Inc.||$250 discount on feasibility testing services for researchers trying to develop COVID-19 assays on a microfluidic cartridge format -- through May 31st.|
|Reveal Biosciences||Discounted rates on image analysis for those working with COVID-19.|
|Sapidyne Instruments Inc.||We will charge the "Additional Measurement" price for any "Initial Measurement" related to COVID-19. This is a 31.5% discount on our services.|
|Simulations Plus, Inc.||StrategiesPlus™ COVID-19 ACT Program, provide “immediate support” for any of our client’s research efforts to help their teams expedite solutions to address the COVID-19 virus. eg GastroPlus®, the only validated, mechanistic PBBM/PBPK lung model, to investigate alternative dosing modalities (inhalation, oral, and various parenteral routes) and optimize dosing to target lung exposure|
|The Solubility Company||Solubility measurements free-of-charge for small molecule and peptide therapeutics intended for the treatment of COVID-19.|
|Venomtech Ltd||10% off targeted venom discovery array|
|Visikol Inc||Priority for COVID-19 projects so they are first to get completed in our lab as well as a 10% discount|
COVID-19-SPECIFIC SERVICES, REAGENTS, MODELS, METHODS, ETC.
|We have an ongoing COVID19
program going on for antibody discovery. We are applying our technology to
develop hopefully optimal antibodies quickly.
|ADS Biosystems Inc.||ADS Biosystems has responded
with the current pandemic and we are generating the viral spike protein (S1
and RBD). Also, we have immunized rabbits and goats to generate the specific
antibodies against the SARS CoV2. Our goal is to provide viral antigen and
antibodies based diagnostics for the outbreak.
|Anabios Corporation||primary human heart and lung
tissue samples across healthy and diseased conditions for pharma (and
academic) groups screening for molecular biomarkers and risk factors for
|Applied Biological Materials||Applied Biologicals Materials,
Inc. (abm) offers a wide range of products for research of the ACE2 receptor,
which is the functional receptor for the spike glycoprotein of human
coronaviruses, including SARS-CoV-2, SARS-CoV, and HCoV-NL63.
|AUM BioTech, LLC||Self-delivering RNA silencing
technology to study virus biology and genetics including coronavirus, improve
target discovery, and facilitate potential therapeutic development for
|Bioqual is currently developing
animal models in mice, hamsters, ferrets and macaques. We have proven
infections with SARSCoV-2 in mice, ferrets and rhesus macaques.
Genomics can provide the primer and probe sequences recommended by the CDC to
researchers working on the coronavirus. The sequences were publically
provided by the CDC here. Researchers can order these primers and probes to
create a panel in their lab, following the panel instructions from the CDC.
These materials are provided for research purposes only.
|KareBay Biochem Inc.||Karebay Bio is currently
manufacturing COVID-19 oligonucleotides for Chinese companies in response to
the pandemic. We are able to do this for companies throughout the world.
COVID-19-specific peptides and proteins, including SARS-CoV-2 Spike RBD
Protein, Nucleocapsid Protein, ACE2 Protein
|Melior Discovery Inc.||Animal models aimed at evaluated
pulmonary challenges such as pulmonary inflammation and pulmonary
fibrosis. We have been receiving a
number in inquiries and are initiating new studies related to this area.
|ACE2 and CD147 humanized animal
models in both mouse and rat species. We will also be producing a number of
ACE2 variants and making ES cell lines readily available to the research
|Genetically encoded fluorescent
assay that would allow researchers to study SARS-CoV-2 entry and ACE2.
|New England Peptide||Many COVID-19-specific peptides|
|We were the first that generated
a whole proteome peptide microarray of the new virus.
|Protavio Ltd - The art in multiplex assays||Luminex assays for diagnosing
immunity to COVID-19, MERS & SARS (IgM/IgG).
|Proteome Sciences plc||Using LC-MS2 Mass Spectrometry
(MS) methods with TMT labelled tryptic peptides, we can analyze how viral
infection changes cellular protein synthesis and abundance, revealing
cellular pathways strongly modulated upon SARS-CoV-2 infection.
antibodies, cytokine arrays, biomarker assays, ELISAs
|Retrovirox||Currently we can perform
pseudovirus assays to evaluate SARS-CoV entry, and also a surrogate assay
with hCoV (OC43) for preliminary testing of coronavirus replication
inhibitors. We anticipate to be able to have the same assay with live
SARS-CoV in 3-4 weeks from now.
proteins and ACE2 proteins
|First company in the world to
offer recombinant proteins of the culprit virus, SARS-COV-2. The company
launched the spike protein on Jan 22nd, 12 days after the sequence is
published. Now the company has developed a comprehensive panel of antigens
and antibodies for this virus. These reagents have been used by over 300
companies and research institutions worldwide for the development of vaccines
and therapeutic antibodies.
|StemCellerant||iPSC-based assay for human lung
cells in response to COVID so researchers can screen therapeutics and model
|Synbio Technologies||Since the
outbreak of COVID-19, Synbio Technologies has set up a special coronavirus
emergency project team, working against time to produce virus-related probes,
genes, and protein products. We are currently providing comprehensive
COVID-19 DNA solutions and working with our clients and partners from
hospitals, scientific research institutes, and enterprises to fight the
|We are offering the SARS-CoV-2
proteins produced recombinantly in HEK293 (mammalian system ). At the moment
the spike S1 protein (RBD) as most important protein is available
off-the-shelf and many other proteins are in the pipeline and should be
available short dated.
Even a GMP compliant production cell line (CHO based) for a viral protein
is under development (protein to be used for immunization / vaccine
|Quick Covid-19 detection kit for
Research Use Only (RUO), neither by RT-PCR nor IgM/IgG. We used a unique
enzyme to perform isothermal amplification, which generates results in 30
|Toronto BioScience||We are currently offering
research-use-only products which includes
recombinant COVID-19 Spike (S) and Nucleocapsid (N) proteins, as well
as ELISA kit detecting human IgG against COVID-19 S or N proteins. ELISA
kit detecting human "IgM" against COVID19 N protein
|Bforcure||Modified qPCR assay can detect
SARS-CoV2 cDNA in less than 10 minutes.
|TransCure bioServices||Screening services to test in
vivo Covid19 antigens for vaccine development, Once ready, the efficacy of
the COVID_19 vaccine could be tested in vivo using our Full human immune
system mouse models.
|Intact Genomics, Inc.||RUO CoV19 detection qPCR kit.
We also provide T4 enzymes and other reagents for developing rapidly Cov19
viral diagnosis kits.
|Daxor||Our blood volume analyzer
BVA-100 optimizes resuscitation in patients with ARDS, respiratory distress,
septic shock etc to reduce time on ventilator, reduce ICU mortality etc.
|Electronmicroscopic Inc. (EMSCOPIC)||Electron microscopy services to
analyze viral-cell interactions specifically shown to work in COVID-19
|Taconic||Ace2 knockout mouse, Tmprss2
Knockout Mouse, Stat1 knockout mice and more
|Services using adipose tissue,
we can provide any researcher with tools necessary to explore the impact of
obesity on outcomes in patients with COVID-19. We have adipose-derived
stromal cells, adipogenic and stromal maintenance media, and a human-derived
3D bioscaffold that are ready to be deployed by researchers as they try to
learn how this virus impacts patients of varying body mass indices.
|Celprogen offers primer sets and
probes for testing of COVID-19 virus via RT-PCR
|Nexelis (formerly PAIRimmune)||In vivo immunogenicity models,
In vivo challenge models (through our partners at PHE), ELISA assays for
multiple antigens, Pseudo-virion based neutralization assay
|STEMCELL Technologies Inc.||Physiologically relevant model
system for in the in vivo airway that has been used in a wide range of
respiratory virus studies, including the SARS-CoV-2
|Biodextris||Nasal vaccine adjuvant platform
which has a good safety profile in human clinical studies, and demonstrated
significant efficacy at viral clearance in preclinical pandemic models,
including SARS-Coronavirus. We believe this adjuvant has high potential value
as a component of a SARS-CoV-2 vaccine, and have material available to
|Epithelix||A platform, based on fully
differentiated in vitro 3D human airway epithelia, is now ready for
evaluating antiviral drugs or therapeutic strategies against SARS-CoV-2
|JPT Peptide Technologies GmbH||SARS-CoV-2-derived
|LKT Labs||On March 22, 2020, an international team of scientists
published a research paper preprint on biorXiv analyzing the interaction
between the novel coronavirus and human proteins. Their analysis predicts 332
protein-protein interactions and 69 existing pharmaceuticals that might
perturb these interactions. The researchers propose that these drugs may be
candidates for treating COVID-19 infections.
We have many of the compounds discussed in that paper in stock and able to
ship within 24 hours.